| Autor: |
ZHENXIONG LIU, WEIJIA DOU, ZHEN NI, QINSHENG WEN, RONG ZHANG, MING QIN, XUXIA WANG, HUA TANG, YING CAO, JINGJIE WANG, SHUGUANG ZHAO |
| Předmět: |
|
| Zdroj: |
Molecular Medicine Reports; 2016, Vol. 14 Issue 2, p1323-1331, 9p |
| Abstrakt: |
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Insulin resistance (IR) is important in the development and progression of NAFLD. Nuclear erythroid 2-related factor 2 (Nrf2) has previously been reported to be a novel regulator in NAFLD. The present study determined that Nrf2 knockdown accelerated the onset of obesity and non-alcoholic steatohepatitis (NASH), via the induction of hepatic IR in mice fed a high-fat diet (HFD), which was confirmed by an increase in total and hepatic weight in Nrf2-null-HFD mice, in addition to marked structural disorder in liver tissues from the Nrf2-null-HFD group analyzed by histopathological examination. Subsequently, it was demonstrated that hepatic IR in Nrf2-null-HFD mice was influenced by oxidative stress; this was confirmed by an increase in malondialdehyde levels and a decrease in glutathione levels. In addition, it was determined that the induction of hepatic IR by Nrf2 knockdown in HFD-treated mice was regulated by activation of the nuclear factor-κB (NF-κB) signaling pathway, as detected by an increase in the expression levels of nuclear NF-κB, and its downstream effectors interleukin-6 and tumor necrosis factor-α. The present study provides insight into the function of Nrf2 in NAFLD, indicating that Nrf2 deletion may lead to hepatic IR by activation of NF-κB, which is often associated with oxidative stress. Therefore, activation of Nrf2 may limit disease progression and act as a therapeutic approach for the treatment of NASH. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
